PUFA Augmentation in Treatment of Major Depression

NCT00067301 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Major Depression

Interventions

DRUG: Polyunsaturated Fatty Acids (PUFA)
DRUG: Citalopram

Sponsor

National Center for Complementary and Integrative Health (NCCIH)